On site-specific glycosylation, our studies of coronavirus spike proteins established MS-based site-specific glycosylation analysis as an integral component of structural glycobiology. Our work (Kuo et al., Glycobiology, 2022), published a year after we obtained the SARS-CoV-2 spike protein trimeric ectodomain construct, is the first to report distinct evolutionary site-specific changes in spike protein glycosylation associated with D614G and Alpha variants, underscoring that the glycan shield is dynamic and must be resolved at individual glycosylation sites. Extending to other coronaviruses, our glycosylation analyses were integrated with cryo-ET/cryo-EM to define alphacoronavirus spike architecture and dynamics (Huang et al., Nature Comm, 2022), incorporated into computational approaches for constructing realistic glycoprotein structures using experimentally informed glycan conformer libraries and steric constraints (Tsai et al., Cell, 2024), and applied in structural analysis of human coronavirus 229E host recognition (Tsai et al., Nature Comm, 2025). These studies provided a demanding test bed for critically evaluating the differences among glycopeptide-analysis software in search strategy, scoring, and glycan assignment. By exploiting their complementary strengths, we developed a practical N-glycopeptide MS/MS workflow that improves confidence in site-specific identification and glycan assignment (Kuo et al., Proteomics, 2023).
The same analytical-to-structural progression was taken further in our study of receptor-type protein tyrosine phosphatase alpha (PTPRA). What began as an effort to define its site-specific glycosylation revealed an exceptionally dense mixture of N- and O-glycans that pushed current bottom-up MS approaches close to their practical limit. Through advanced LC-MS/MS and complementary proteolysis, including O-glycoproteases, we achieved extensive site-resolved characterization of this highly heterogeneous ectodomain. The work then expanded into a collaboration involving four IBC laboratories and Japanese investigators, integrating MS with high-speed AFM, biophysical analysis and molecular modeling. This showed that dense N- and O-glycosylation forms a protective molecular shield and constrains the dimensions and dynamics of the intrinsically disordered PTPRA ectodomain (Chien et al., JACS Au, 2023).